ロード中...
Transient antiretroviral therapy selecting for common HIV-1 mutations substantially accelerates the appearance of rare mutations
BACKGROUND: Highly selective antiretroviral (ARV) regimens such as single dose nevirapine (NVP) used for prevention of mother to child transmission (PMTCT) in resource-limited settings produce transient increases in otherwise marginal subpopulations of cells infected by mutant genomes. The longer te...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2008
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2605440/ https://ncbi.nlm.nih.gov/pubmed/19014593 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1742-4682-5-25 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|